Skip to content
10-Q

Quarterly Report

MEDICINOVA, INC. MNOV

0000950170-24-056996

← back to feed
Filed
May 9, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 7, 2024 49.05M sh
Cash And Equivalents Q1 2024 · Mar 31, 2024 $47.14M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $51M
Current Liabilities Q1 2024 · Mar 31, 2024 $2.51M
Current Liabilities Q1 2024 · Dec 31, 2023 $3.28M
Total Liabilities Q1 2024 · Mar 31, 2024 $3.06M
Total Liabilities Q1 2024 · Dec 31, 2023 $3.89M
Current Assets Q1 2024 · Mar 31, 2024 $47.86M
Current Assets Q1 2024 · Dec 31, 2023 $51.17M
Total Assets Q1 2024 · Mar 31, 2024 $62.89M
Total Assets Q1 2024 · Dec 31, 2023 $66.27M
Shares Diluted Q1 2024 · Mar 31, 2023 49.05M sh
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$3.18M
Stockholders Equity Q1 2024 · Mar 31, 2023 $67.73M
Stockholders Equity Q1 2024 · Dec 31, 2022 $70.24M
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.06
Eps Basic Q1 2024 · Mar 31, 2023 −$0.06
Sga Expense Q1 2024 · Mar 31, 2023 $1.49M
Rd Expense Q1 2024 · Mar 31, 2023 $1.4M
Net Income Q1 2024 · Mar 31, 2023 −$2.92M
Operating Income Q1 2024 · Mar 31, 2023 −$2.96M